Found: 28
Select item for more details and to access through your institution.
ShorTrip Trial: A Prospective, Multicentric Phase H Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 3, p. 339, doi. 10.1016/j.clcc.2023.06.002
- By:
- Publication type:
- Article
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 314, doi. 10.1016/j.clcc.2021.07.001
- By:
- Publication type:
- Article
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 219, doi. 10.1016/j.clcc.2020.04.009
- By:
- Publication type:
- Article
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 191, doi. 10.1016/j.clcc.2020.03.009
- By:
- Publication type:
- Article
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245635, doi. 10.1001/jamanetworkopen.2024.5635
- By:
- Publication type:
- Article
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39525-3
- By:
- Publication type:
- Article
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 957, doi. 10.1038/s41416-022-01852-0
- By:
- Publication type:
- Article
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
- Published in:
- 2022
- By:
- Publication type:
- journal article
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications.
- Published in:
- 2022
- By:
- Publication type:
- journal article
EGFR Amplification in Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 493, doi. 10.1007/s00432-019-03077-w
- By:
- Publication type:
- Article
FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 302, doi. 10.1002/onco.13642
- By:
- Publication type:
- Article
Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1178, doi. 10.1634/theoncologist.2017-0573
- By:
- Publication type:
- Article
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 8, p. 988, doi. 10.1634/theoncologist.2016-0084
- By:
- Publication type:
- Article
Liquid chromatographic/electrospray ionization quadrupole/time of flight tandem mass spectrometric study of polyphenolic composition of different Vaccinium berry species and their comparative evaluation.
- Published in:
- Analytical & Bioanalytical Chemistry, 2017, v. 409, n. 5, p. 1347, doi. 10.1007/s00216-016-0067-y
- By:
- Publication type:
- Article
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5451, doi. 10.3390/cancers15225451
- By:
- Publication type:
- Article
Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Resection for Colorectal Liver Metastases at the Hepatocaval Confluence.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4683, doi. 10.3390/cancers15194683
- By:
- Publication type:
- Article
Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1259, doi. 10.3390/cancers12051259
- By:
- Publication type:
- Article
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1022, doi. 10.3390/cancers12041022
- By:
- Publication type:
- Article
Merkel Cell Carcinoma of the Retroperitoneum with No Identifiable Primary Site.
- Published in:
- Case Reports in Oncological Medicine, 2013, p. 1, doi. 10.1155/2013/131695
- By:
- Publication type:
- Article
Neural embeddings: accurate and readable inferences based on semantic kernels.
- Published in:
- Natural Language Engineering, 2019, v. 25, n. 4, p. 519, doi. 10.1017/S1351324919000238
- By:
- Publication type:
- Article
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article